✦ LIBER ✦

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

✍ Scribed by Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 275 KB
Volume: 258
Category: Article
ISSN: 1433-8491
DOI: 10.1007/s00406-007-0800-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of cognitive dysfunction in ch

Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist

✍ Danijela Piškulić; James S. Olver; Paul Maruff; Trevor R. Norman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Objectives To assess effects of a semi‐acute administration of buspirone in comparison to a placebo on cognitive function and negative symptoms in patients with schizophrenia and schizoaffective disorder. ## Methods In a 6‐week, double‐blind, placebo‐controlled, independent groups

Role of dopamine D3 receptor (DRD3) and

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

✍ György Szekeres; Szabolcs Kéri; Anna Juhász; Ágnes Rimanóczy; István Szendi; Cso 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract Molecular components of the dopaminergic system may play an important role in the pathophysiology of schizophrenia. In this study, we investigated the relationship of the Ser9Gly (S/G) polymorphism of the dopamine D3 receptor (DRD3) and the variable number of tandem repeats (VNTR) polym